-
1
-
-
0032535770
-
A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995
-
[see comments]
-
Hundahl S.A., Fleming I.D., Fremgen A.M., et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. [see comments]. Cancer 83 12 (1998) 2638-2648
-
(1998)
Cancer
, vol.83
, Issue.12
, pp. 2638-2648
-
-
Hundahl, S.A.1
Fleming, I.D.2
Fremgen, A.M.3
-
2
-
-
0031028402
-
Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991
-
Gilliland F.D., Hunt W.C., Morris D.M., et al. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer 79 3 (1997) 564-573
-
(1997)
Cancer
, vol.79
, Issue.3
, pp. 564-573
-
-
Gilliland, F.D.1
Hunt, W.C.2
Morris, D.M.3
-
3
-
-
33646442046
-
Increasing incidence of thyroid cancer in the United States, 1973-2002
-
Davies L., and Welch H.G. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295 18 (2006) 2164-2167
-
(2006)
JAMA
, vol.295
, Issue.18
, pp. 2164-2167
-
-
Davies, L.1
Welch, H.G.2
-
4
-
-
85047681191
-
Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer
-
Mazzaferri E.L., and Kloos R.T. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86 4 (2001) 1447-1463
-
(2001)
J Clin Endocrinol Metab
, vol.86
, Issue.4
, pp. 1447-1463
-
-
Mazzaferri, E.L.1
Kloos, R.T.2
-
5
-
-
0024232116
-
An expanded view of risk-group definition in differentiated thyroid carcinoma
-
Cady B., and Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104 6 (1988) 947-953
-
(1988)
Surgery
, vol.104
, Issue.6
, pp. 947-953
-
-
Cady, B.1
Rossi, R.2
-
6
-
-
0037003313
-
Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin
-
Mazzaferri E.L., and Massoll N. Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin. Endocr Relat Cancer 9 4 (2002) 227-247
-
(2002)
Endocr Relat Cancer
, vol.9
, Issue.4
, pp. 227-247
-
-
Mazzaferri, E.L.1
Massoll, N.2
-
7
-
-
3242693043
-
Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases
-
Torlontano M., Attard M., Crocetti U., et al. Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. J Clin Endocrinol Metab 89 7 (2004) 3402-3407
-
(2004)
J Clin Endocrinol Metab
, vol.89
, Issue.7
, pp. 3402-3407
-
-
Torlontano, M.1
Attard, M.2
Crocetti, U.3
-
8
-
-
34548046458
-
Will highly sensitive thyroglobulin assays change the management of thyroid cancer?
-
Mazzaferri E.L. Will highly sensitive thyroglobulin assays change the management of thyroid cancer?. Clin Endocrinol (Oxf) 67 3 (2007) 321-323
-
(2007)
Clin Endocrinol (Oxf)
, vol.67
, Issue.3
, pp. 321-323
-
-
Mazzaferri, E.L.1
-
9
-
-
0019777718
-
The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancer
-
Ashcraft M.W., and Van Herle A.J. The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancer. Am J Med 71 5 (1981) 806-814
-
(1981)
Am J Med
, vol.71
, Issue.5
, pp. 806-814
-
-
Ashcraft, M.W.1
Van Herle, A.J.2
-
10
-
-
0028049352
-
Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma
-
Lubin E., Mechlis-Frish S., Zatz S., et al. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma. J Nucl Med 35 2 (1994) 257-262
-
(1994)
J Nucl Med
, vol.35
, Issue.2
, pp. 257-262
-
-
Lubin, E.1
Mechlis-Frish, S.2
Zatz, S.3
-
11
-
-
24344489445
-
A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later
-
Kloos R.T., and Mazzaferri E.L. A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later. J Clin Endocrinol Metab 90 9 (2005) 5047-5057
-
(2005)
J Clin Endocrinol Metab
, vol.90
, Issue.9
, pp. 5047-5057
-
-
Kloos, R.T.1
Mazzaferri, E.L.2
-
12
-
-
0027243685
-
Fine-needle biopsy of cervical lymph nodes in patients with thyroid cancer: a prospective comparison of cytopathologic and tissue marker analysis
-
Lee M.J., Ross D.S., Mueller P.R., et al. Fine-needle biopsy of cervical lymph nodes in patients with thyroid cancer: a prospective comparison of cytopathologic and tissue marker analysis. Radiology 187 3 (1993) 851-854
-
(1993)
Radiology
, vol.187
, Issue.3
, pp. 851-854
-
-
Lee, M.J.1
Ross, D.S.2
Mueller, P.R.3
-
13
-
-
0035948197
-
Ultrasound-guided fine-needle aspiration biopsy of the thyroid bed
-
Krishnamurthy S., Bedi D.G., and Caraway N.P. Ultrasound-guided fine-needle aspiration biopsy of the thyroid bed. Cancer 93 3 (2001) 199-205
-
(2001)
Cancer
, vol.93
, Issue.3
, pp. 199-205
-
-
Krishnamurthy, S.1
Bedi, D.G.2
Caraway, N.P.3
-
14
-
-
0033674689
-
Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma
-
Frilling A., Gorges R., Tecklenborg K., et al. Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma. Surgery 128 6 (2000) 1067-1074
-
(2000)
Surgery
, vol.128
, Issue.6
, pp. 1067-1074
-
-
Frilling, A.1
Gorges, R.2
Tecklenborg, K.3
-
15
-
-
0036280909
-
Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment
-
Pacini F., Capezzone M., Elisei R., et al. Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. J Clin Endocrinol Metab 87 4 (2002) 1499-1501
-
(2002)
J Clin Endocrinol Metab
, vol.87
, Issue.4
, pp. 1499-1501
-
-
Pacini, F.1
Capezzone, M.2
Elisei, R.3
-
16
-
-
34447622455
-
Followup of patients with papillary thyroid cancer: in search of the optimal algorithm
-
Mittendorf E.A., Wang X., Perrier N.D., et al. Followup of patients with papillary thyroid cancer: in search of the optimal algorithm. J Am Coll Surg 205 2 (2007) 239-247
-
(2007)
J Am Coll Surg
, vol.205
, Issue.2
, pp. 239-247
-
-
Mittendorf, E.A.1
Wang, X.2
Perrier, N.D.3
-
17
-
-
0036281001
-
Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?
-
Mazzaferri E.L., and Kloos R.T. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?. J Clin Endocrinol Metab 87 4 (2002) 1490-1498
-
(2002)
J Clin Endocrinol Metab
, vol.87
, Issue.4
, pp. 1490-1498
-
-
Mazzaferri, E.L.1
Kloos, R.T.2
-
18
-
-
0032589873
-
Non-131I-scintigraphy in the treatment and follow-up of thyroid cancer. Single-photon-emitters or FDG-PET?
-
Grunwald F., Briele B., and Biersack H.J. Non-131I-scintigraphy in the treatment and follow-up of thyroid cancer. Single-photon-emitters or FDG-PET?. Q J Nucl Med 43 3 (1999) 195-206
-
(1999)
Q J Nucl Med
, vol.43
, Issue.3
, pp. 195-206
-
-
Grunwald, F.1
Briele, B.2
Biersack, H.J.3
-
19
-
-
0025005762
-
Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma?
-
Ronga G., Fiorentino A., Paserio E., et al. Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma?. J Nucl Med 31 11 (1990) 1766-1771
-
(1990)
J Nucl Med
, vol.31
, Issue.11
, pp. 1766-1771
-
-
Ronga, G.1
Fiorentino, A.2
Paserio, E.3
-
20
-
-
0031742512
-
Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases
-
Unal S., Menda Y., Adalet I., et al. Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases. J Nucl Med 39 11 (1998) 1897-1902
-
(1998)
J Nucl Med
, vol.39
, Issue.11
, pp. 1897-1902
-
-
Unal, S.1
Menda, Y.2
Adalet, I.3
-
21
-
-
0031893404
-
Thallium-201 uptake with negative iodine-131 scintigraphy and serum thyroglobulin in metastatic oxyphilic papillary thyroid carcinoma
-
Harder W., Lind P., Molnar M., et al. Thallium-201 uptake with negative iodine-131 scintigraphy and serum thyroglobulin in metastatic oxyphilic papillary thyroid carcinoma. J Nucl Med 39 2 (1998) 236-238
-
(1998)
J Nucl Med
, vol.39
, Issue.2
, pp. 236-238
-
-
Harder, W.1
Lind, P.2
Molnar, M.3
-
22
-
-
0031966884
-
Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma
-
Gallowitsch H.J., Mikosch P., Kresnik E., et al. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma. J Nucl Med 39 5 (1998) 870-875
-
(1998)
J Nucl Med
, vol.39
, Issue.5
, pp. 870-875
-
-
Gallowitsch, H.J.1
Mikosch, P.2
Kresnik, E.3
-
23
-
-
30344488437
-
Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy
-
Torlontano M., Crocetti U., Augello G., et al. Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy. J Clin Endocrinol Metab 91 1 (2006) 60-63
-
(2006)
J Clin Endocrinol Metab
, vol.91
, Issue.1
, pp. 60-63
-
-
Torlontano, M.1
Crocetti, U.2
Augello, G.3
-
24
-
-
0023099793
-
Sonography in the follow-up of 100 patients with thyroid carcinoma
-
Simeone J.F., Daniels G.H., Hall D.A., et al. Sonography in the follow-up of 100 patients with thyroid carcinoma. AJR Am J Roentgenol 148 1 (1987) 45-49
-
(1987)
AJR Am J Roentgenol
, vol.148
, Issue.1
, pp. 45-49
-
-
Simeone, J.F.1
Daniels, G.H.2
Hall, D.A.3
-
25
-
-
0037216216
-
Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma
-
Frasoldati A., Pesenti M., Gallo M., et al. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer 97 1 (2003) 90-96
-
(2003)
Cancer
, vol.97
, Issue.1
, pp. 90-96
-
-
Frasoldati, A.1
Pesenti, M.2
Gallo, M.3
-
26
-
-
0023808716
-
US-guided biopsy of neck masses in postoperative management of patients with thyroid cancer
-
Sutton R.T., Reading C.C., Charboneau J.W., et al. US-guided biopsy of neck masses in postoperative management of patients with thyroid cancer. Radiology 168 3 (1988) 769-772
-
(1988)
Radiology
, vol.168
, Issue.3
, pp. 769-772
-
-
Sutton, R.T.1
Reading, C.C.2
Charboneau, J.W.3
-
27
-
-
0031434133
-
High-resolution ultrasound associated with aspiration biopsy in the follow-up of patients with differentiated thyroid cancer
-
Rodriguez J.M., Reus M., Moreno A., et al. High-resolution ultrasound associated with aspiration biopsy in the follow-up of patients with differentiated thyroid cancer. Otolaryngol Head Neck Surg 117 6 (1997) 694-697
-
(1997)
Otolaryngol Head Neck Surg
, vol.117
, Issue.6
, pp. 694-697
-
-
Rodriguez, J.M.1
Reus, M.2
Moreno, A.3
-
28
-
-
0033405775
-
Fluorine-18 fluorodeoxyglucose dual-head positron emission tomography in the detection of recurrent differentiated thyroid cancer: preliminary results
-
Stokkel M.P., de Klerk J.H., Zelissen P.M., et al. Fluorine-18 fluorodeoxyglucose dual-head positron emission tomography in the detection of recurrent differentiated thyroid cancer: preliminary results. Eur J Nucl Med 26 12 (1999) 1606-1609
-
(1999)
Eur J Nucl Med
, vol.26
, Issue.12
, pp. 1606-1609
-
-
Stokkel, M.P.1
de Klerk, J.H.2
Zelissen, P.M.3
-
29
-
-
34047214644
-
18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer
-
Shammas A., Degirmenci B., Mountz J.M., et al. 18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer. J Nucl Med 48 2 (2007) 221-226
-
(2007)
J Nucl Med
, vol.48
, Issue.2
, pp. 221-226
-
-
Shammas, A.1
Degirmenci, B.2
Mountz, J.M.3
-
30
-
-
0036009138
-
Implication of 2-18fluor-2-deoxyglucose positron emission tomography in the follow-up of Hurthle cell thyroid cancer
-
Plotkin M., Hautzel H., Krause B.J., et al. Implication of 2-18fluor-2-deoxyglucose positron emission tomography in the follow-up of Hurthle cell thyroid cancer. Thyroid 12 2 (2002) 155-161
-
(2002)
Thyroid
, vol.12
, Issue.2
, pp. 155-161
-
-
Plotkin, M.1
Hautzel, H.2
Krause, B.J.3
-
31
-
-
13444301390
-
The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma
-
Nahas Z., Goldenberg D., Fakhry C., et al. The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma. Laryngoscope 115 2 (2005) 237-243
-
(2005)
Laryngoscope
, vol.115
, Issue.2
, pp. 237-243
-
-
Nahas, Z.1
Goldenberg, D.2
Fakhry, C.3
-
32
-
-
4444366490
-
The clinical impact of 18F-FDG gamma PET in patients with recurrent well differentiated thyroid carcinoma
-
Goshen E., Cohen O., Rotenberg G., et al. The clinical impact of 18F-FDG gamma PET in patients with recurrent well differentiated thyroid carcinoma. Nucl Med Commun 24 9 (2003) 959-961
-
(2003)
Nucl Med Commun
, vol.24
, Issue.9
, pp. 959-961
-
-
Goshen, E.1
Cohen, O.2
Rotenberg, G.3
-
33
-
-
0035209518
-
Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma
-
Frilling A., Tecklenborg K., Gorges R., et al. Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma. Ann Surg 234 6 (2001) 804-811
-
(2001)
Ann Surg
, vol.234
, Issue.6
, pp. 804-811
-
-
Frilling, A.1
Tecklenborg, K.2
Gorges, R.3
-
34
-
-
0032871248
-
Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography
-
Conti P.S., Durski J.M., Bacqai F., et al. Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography. Thyroid 9 8 (1999) 797-804
-
(1999)
Thyroid
, vol.9
, Issue.8
, pp. 797-804
-
-
Conti, P.S.1
Durski, J.M.2
Bacqai, F.3
-
35
-
-
33745429077
-
Role of [18F]fluorodeoxyglucose positron emission tomography in follow-up of differentiated thyroid cancer
-
Alzahrani A.S., Mohamed G.E., Al Rifai A., et al. Role of [18F]fluorodeoxyglucose positron emission tomography in follow-up of differentiated thyroid cancer. Endocr Pract 12 2 (2006) 152-158
-
(2006)
Endocr Pract
, vol.12
, Issue.2
, pp. 152-158
-
-
Alzahrani, A.S.1
Mohamed, G.E.2
Al Rifai, A.3
-
36
-
-
0034130683
-
FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma
-
Alnafisi N.S., Driedger A.A., Coates G., et al. FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma. J Nucl Med 41 6 (2000) 1010-1015
-
(2000)
J Nucl Med
, vol.41
, Issue.6
, pp. 1010-1015
-
-
Alnafisi, N.S.1
Driedger, A.A.2
Coates, G.3
-
37
-
-
33646205501
-
The value of FDG-PET in the follow-up of differentiated thyroid cancer: a review of the literature
-
Stokkel M.P., Duchateau C.S., and Dragoiescu C. The value of FDG-PET in the follow-up of differentiated thyroid cancer: a review of the literature. Q J Nucl Med Mol Imaging 50 1 (2006) 78-87
-
(2006)
Q J Nucl Med Mol Imaging
, vol.50
, Issue.1
, pp. 78-87
-
-
Stokkel, M.P.1
Duchateau, C.S.2
Dragoiescu, C.3
-
38
-
-
32544437659
-
Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning
-
Robbins R.J., Wan Q., Grewal R.K., et al. Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning. J Clin Endocrinol Metab 91 2 (2006) 498-505
-
(2006)
J Clin Endocrinol Metab
, vol.91
, Issue.2
, pp. 498-505
-
-
Robbins, R.J.1
Wan, Q.2
Grewal, R.K.3
-
39
-
-
0037849895
-
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma
-
Mazzaferri E.L., Robbins R.J., Spencer C.A., et al. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 88 4 (2003) 1433-1441
-
(2003)
J Clin Endocrinol Metab
, vol.88
, Issue.4
, pp. 1433-1441
-
-
Mazzaferri, E.L.1
Robbins, R.J.2
Spencer, C.A.3
-
40
-
-
33745684505
-
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
-
Pacini F., Schlumberger M., Dralle H., et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154 6 (2006) 787-803
-
(2006)
Eur J Endocrinol
, vol.154
, Issue.6
, pp. 787-803
-
-
Pacini, F.1
Schlumberger, M.2
Dralle, H.3
-
41
-
-
33645465719
-
Management guidelines for patients with thyroid nodules and differentiated thyroid cancer
-
Cooper D.S., Doherty G.M., Haugen B.R., et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16 2 (2006) 109-142
-
(2006)
Thyroid
, vol.16
, Issue.2
, pp. 109-142
-
-
Cooper, D.S.1
Doherty, G.M.2
Haugen, B.R.3
-
42
-
-
33846437453
-
The role of PET in follow-up of patients treated for differentiated epithelial thyroid cancers
-
Leboulleux S., Schroeder P.R., Schlumberger M., et al. The role of PET in follow-up of patients treated for differentiated epithelial thyroid cancers. Nat Clin Pract Endocrinol Metab 3 2 (2007) 112-121
-
(2007)
Nat Clin Pract Endocrinol Metab
, vol.3
, Issue.2
, pp. 112-121
-
-
Leboulleux, S.1
Schroeder, P.R.2
Schlumberger, M.3
-
43
-
-
24044476177
-
Papillary thyroid cancer: medical management and follow-up
-
Kloos R.T. Papillary thyroid cancer: medical management and follow-up. Curr Treat Options Oncol 6 4 (2005) 323-338
-
(2005)
Curr Treat Options Oncol
, vol.6
, Issue.4
, pp. 323-338
-
-
Kloos, R.T.1
|